CliffBio
small molecule

CHLORPROMAZINE HYDROCHLORIDE

CHLORPROMAZINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameCHLORPROMAZINE HYDROCHLORIDE
Active ingredientCHLORPROMAZINE HYDROCHLORIDE
Strength100MG/ML
Dosage formCONCENTRATE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2021
Marketing statusRX

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CHLORPROMAZINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio